Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Longs, there is something else to be gleaned from / Kirk

Yep, while it is a bit tough to put on my rose colored glasses this am, I will. It is always better than the alternative.

  1. PTSC still has of cash
  2. PTSC has more, make that much more, licenses to be collected, IMO.
  3. The USPTO review will come sooner than later. IMO, less than six months out and that's not so long in the big picture view.
  4. Our new CEO has stated very clearly he on the M & A hunt and I believe his experience will work out well for us.
  5. PTSC's monthly burn rate is very small and we should have a great looking financial statement for several Qs to come -- a BIG plus for Wall Steet should we get noticed.

OK, now the dark side: The Q report was not even close to our expectations and we do not know what is included. Hmmm...that does smell at bit today and the pps reflects it. Maybe tomarrow will bring a better scent.

Off to whack a small ball around a large groomed pasture into a small hole.

John

Share
New Message
Please login to post a reply